Planet 13 Holdings PLNH
OTC PLNH
$0.16 +0.01 (+5.63%)
As of: Aug 21, 2026 · 3:59 PM EDT

Planet 13 Holdings (PLNH) Non-Current Assets (2021 - 2026)

Planet 13 Holdings (PLNH) posted quarterly Non-Current Assets of $109.1 million for Q1 2026, down 28.26% year-over-year from $152.1 million in Q1 2025, and down 1.85% quarter-over-quarter from $111.1 million in Q4 2025.

Planet 13 Holdings (PLNH) Non-Current Assets (2021 - 2026) Analysis & Trends

Planet 13 Holdings (PLNH) has reported Non-Current Assets for 6 consecutive years, with $109.1 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Non-Current Assets fell 28.26% year-over-year to $109.1 million; the TTM figure through Mar 2026 stood at $484.9 million (down 28.38% YoY), while the FY2025 annual figure was $111.1 million, down 27.09% from the prior year.
  • Non-Current Assets slipped to $109.1 million in Q1 2026 per PLNH's latest filing, from $111.1 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $197.2 million in Q2 2022 and bottomed at $104.4 million in Q4 2023.
  • Historically, Non-Current Assets has averaged $151.1 million across 5 years, with a median of $152.4 million in 2024.
  • Annual changes were most pronounced in 2024 — Non-Current Assets soared 51.07% — and 2025, when it slumped 38.61%.
  • Planet 13 Holdings' Non-Current Assets stood at $163.1 million in 2022, then tumbled by 35.98% to $104.4 million in 2023, then surged by 45.96% to $152.4 million in 2024, then retreated by 27.09% to $111.1 million in 2025, then dropped by 1.85% to $109.1 million in 2026.
  • Business Quant data shows PLNH's Non-Current Assets at $109.1 million in Q1 2026, $111.1 million in Q4 2025, and $113.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - 37.96 Bn
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn 26.10 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn 8.72 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 78.51 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 3.74 Bn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn 24.99 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 3.72 Bn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn 9.76 Bn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - 2.96 Bn
10 Planet 13 Holdings 52.64 Mn 36.16 Mn 12.32 Mn 106.82 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 106.82 Mn
Mar 31, 2026 109.08 Mn
Dec 31, 2025 111.14 Mn
Sep 30, 2025 113.43 Mn
Jun 30, 2025 151.21 Mn
Mar 31, 2025 152.06 Mn
Dec 31, 2024 152.44 Mn
Sep 30, 2024 184.78 Mn
Jun 30, 2024 187.76 Mn
Mar 31, 2024 104.64 Mn
Dec 31, 2023 104.44 Mn
Sep 30, 2023 122.31 Mn
Jun 30, 2023 163.36 Mn
Mar 31, 2023 166.01 Mn
Dec 31, 2022 163.13 Mn
Sep 30, 2022 194.78 Mn
Jun 30, 2022 197.15 Mn
Mar 31, 2022 191.02 Mn
Dec 31, 2021 135.80 Mn